Evidence map›Paper›PMID 33327494›Full record

ArticleBiomedicines2020

Combinatorial Effect of Magnetic Field and Radiotherapy in PDAC Organoids: A Pilot Study.

Luca Nicosia, Filippo Alongi, Silvia Andreani, Ruggero Ruggieri, Borislav Rusev, Beatrice Mantoan, Rita Teresa Lawlor, Antonio Pea, Aldo Scarpa, Linda Agolli and 2 more

Open access · goldAbstract read
In one paragraph

Article in Biomedicines, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Tumor organoids modeling reveals timed responses and interplay of radiotherapy and chemotherapy in pancreatic cancer.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. New Insights in Radiotherapy.Biomedicines · 2022
    Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Luca NicosiaAdvanced Radiation Oncology Department, IRCCS Sacro Cuore Don Calabria Hospital, Cancer Care Center, 37024 Negrar, Italy.
Filippo AlongiAdvanced Radiation Oncology Department, IRCCS Sacro Cuore Don Calabria Hospital, Cancer Care Center, 37024 Negrar, Italy.
Silvia AndreaniARC-Net Research Centre, University and Hospital Trust of Verona, 37134 Verona, Italy.ORCID 0000-0002-3715-1553
Ruggero RuggieriAdvanced Radiation Oncology Department, IRCCS Sacro Cuore Don Calabria Hospital, Cancer Care Center, 37024 Negrar, Italy.
Borislav RusevARC-Net Research Centre, University and Hospital Trust of Verona, 37134 Verona, Italy.
Beatrice MantoanAdvanced Radiation Oncology Department, IRCCS Sacro Cuore Don Calabria Hospital, Cancer Care Center, 37024 Negrar, Italy.
Rita Teresa LawlorARC-Net Research Centre, University and Hospital Trust of Verona, 37134 Verona, Italy.ORCID 0000-0003-3160-0634
Antonio PeaGeneral and Pancreatic Surgery Department, Pancreas Institute, University and Hospital Trust of Verona, 37134 Verona, Italy.
Aldo ScarpaARC-Net Research Centre, University and Hospital Trust of Verona, 37134 Verona, Italy.ORCID 0000-0003-1678-739X
Linda AgolliDepartment of Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität, Fetscherstraße 74, 01307 Dresden, Germany.
Vincenzo CorboARC-Net Research Centre, University and Hospital Trust of Verona, 37134 Verona, Italy.ORCID 0000-0002-6340-8009
Sabrina D'AgostoDepartment of Diagnostics and Public Health, University and Hospital Trust of Verona, 37134 Verona, Italy.ORCID 0000-0003-0950-9914
University of Verona · ITOspedale Sacro Cuore Don Calabria · ITOncoRay · DE

Funding

Associazione Italiana per la Ricerca sul Cancro 12182Associazione Italiana per la Ricerca sul Cancro 18718Associazione Italiana per la Ricerca sul Cancro 24043
6 · The paper itself

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is highly refractory to systemic treatment, including radiotherapy (RT) either as alone or in combination with chemotherapy. Magnetic resonance (MR)-guided RT is a novel treatment technique which conjugates the high MR imaging contrast resolution to the possibility of re-adapting treatment plan to daily anatomical variations. Magnetic field (MF) might exert a biological effect that could be exploited to enhance radiation effect. The aim of the present study was to lay the preclinical basis of the MF effect by exploring how it modifies the response to radiation in organoid cultures established from PDAC. The short-term effect of radiation, alone or in combination with MF, was evaluated in patient-derived organoids (PDOs) and monolayer cell cultures. Cell viability, apoptotic cell death, and organoid size following exposure to the treatment were evaluated. PDOs demonstrated limited sensitivity at clinically relevant doses of radiation. The combination of radiation and MF demonstrated superior efficacy than monotherapy in almost all the PDOs tested. PDOs treated with combination of radiation and MF were significantly smaller in size and some showed increased cell death as compared to the monotherapy with radiation. Long-time exposure to 1.5T MF can increase the therapeutic efficacy of radiation in PDAC organoids.

Indexed as

3D organoidsmagnetic fieldMR-guided radiotherapyMR-Linacpatient-derived modelsradiotherapy

Identifiers

PMID33327494
PMCPMC7765003
OpenAlexW3111223520

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.